BioStem Technologies, Inc. (BSEM)
3.82
-0.10
(-2.55%)
USD |
NASDAQ |
Aug 25, 16:00
3.82
0.00 (0.00%)
After-Hours: 16:27
BioStem Technologies Net Income (Quarterly) : -8.971M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.971M |
| March 31, 2026 | -8.820M |
| December 31, 2025 | -11.26M |
| September 30, 2025 | 0.7611M |
| June 30, 2025 | 0.0106M |
| March 31, 2025 | 3.908M |
| December 31, 2024 | 14.67M |
| September 30, 2024 | 6.820M |
| June 30, 2024 | 6.286M |
| March 31, 2024 | 3.258M |
| December 31, 2023 | -2.742M |
| September 30, 2023 | -1.538M |
| June 30, 2023 | -2.855M |
| March 31, 2023 | -3.580M |
| December 31, 2022 | -3.771M |
| September 30, 2022 | -0.8878M |
| June 30, 2022 | 0.3238M |
| March 31, 2022 | -2.767M |
| December 31, 2021 | -0.287M |
| September 30, 2021 | -0.4583M |
| June 30, 2021 | -0.3717M |
| Date | Value |
|---|---|
| March 31, 2021 | -0.1295M |
| December 31, 2020 | -0.5311M |
| September 30, 2020 | -0.7248M |
| June 30, 2020 | -0.6998M |
| March 31, 2020 | -0.3902M |
| June 30, 2019 | -2.097M |
| March 31, 2019 | -2.400M |
| December 31, 2018 | -3.798M |
| September 30, 2018 | -1.726M |
| June 30, 2018 | -0.8702M |
| March 31, 2018 | -1.344M |
| December 31, 2017 | -0.3842M |
| September 30, 2017 | -1.592M |
| June 30, 2017 | -1.624M |
| March 31, 2017 | -0.2658M |
| December 31, 2016 | -1.279M |
| September 30, 2016 | -2.186M |
| June 30, 2016 | -2.186M |
| March 31, 2016 | -0.4973M |
| June 30, 2014 | -0.113M |
| March 31, 2014 | -0.1098M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -8.603M |
| CorMedix, Inc. | 25.99M |
| Eloxx Pharmaceuticals, Inc. | -4.502M |
| Cannabis Global, Inc. | -0.062M |
| Breakthrough Chemistry, Inc. | -1.083M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 7.899M |
| Total Expenses (Quarterly) | 16.87M |
| EPS Diluted (Quarterly) | -0.5178 |
| Enterprise Value | 64.12M |
| Gross Profit Margin (Quarterly) | 52.55% |
| Profit Margin (Quarterly) | -113.6% |
| Earnings Yield | -43.94% |
| Normalized Earnings Yield | -43.94 |